The Coronavirus Disease 2019 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated With Nirmatrelvir Plus Ritonavir Versus Untreated Controls.

Saved in:
Bibliographic Details
Title: The Coronavirus Disease 2019 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated With Nirmatrelvir Plus Ritonavir Versus Untreated Controls.
Authors: Pandit JA; Scripps Research Translational Institute, La Jolla, California, USA., Radin JM; Scripps Research Translational Institute, La Jolla, California, USA., Chiang DC; Scripps Research Translational Institute, La Jolla, California, USA., Spencer EG; Scripps Research Translational Institute, La Jolla, California, USA., Pawelek JB; Scripps Research Translational Institute, La Jolla, California, USA., Diwan M; Scripps Research Translational Institute, La Jolla, California, USA., Roumani L; eMed, Miami, Florida, USA., Mina MJ; eMed, Miami, Florida, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 05; Vol. 77 (1), pp. 25-31.
Publication Type: Observational Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciad102